Urology

Our vision of urology

• To develop a distinctive voice in the international urological community in research, innovation and education to improve the lives of people with urological diseases. 
• To create a vibrant environment where collaborative work to improve the diagnosis and management of urological conditions is championed, and patient focused research is key to the clinical management both today and in the future.

Our experts

Selected Publications 

1. Dinneen E, Grierson J, Almeida-Magana R, Clow R, Haider A, Allen C, Heffernan-Ho D, ... Kelly J, Shaw G. (2022). NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer. Trials. 2022 Jul 22;23(1):584. PMID: 35869497
2. Pang KH, Girling B, Osinibi E, Sawhney P, ... Muneer A, Alifrangis C, Alnajjar HM. (2023). Outcomes of penile sarcomatoid squamous cell carcinoma from a single tertiary referral centre: a matched cohort study. BJU Int. 2023 May 11. PMID: 37169730
3. Schifano N, Fallara G, Rezvani S, Pozzi E, Churchill J, Castiglione F, ... Muneer A. (2023). Outcomes following radical inguinal lymphadenectomy for penile cancer using a fascial-sparing surgical technique. World J Urol. 2023 Apr 5.
4. Warren H, Palumbo C, Caliò A, Tran MGB, Campi R; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. (2023). Oncocytoma on renal mass biopsy: why is surgery even performed? World J Urol. 2023 Apr 21. PMID: 37084134
5. Aquilina J, Neves JB, El-Sheikh S, Tran-Dang MA, Walkden M, Barod R, Patki P, Mumtaz F, Bex A, Tran MGB. (2023). Epitheloid Angiomyolipomas of the Kidney: Rare Renal Tumors Associated With Poor Prognoses. Urology. 2023 Apr 6:S0090-4295(23)00265-0.
6. Wells L, Ahmed K, Ralph DJ, Muneer A. (2022). Development and content validation of a competency-based assessment tool for penile prosthesis surgery. Int J Impot Res. 2022 Mar;34(2):187-194. Epub 2021 Mar 24.PMID: 33762713
7. Pang KH, Randhawa K, Tang S, ... Ralph DJ, Muneer A, Alnajjar HM. (2023). Complications and outcomes following injection of foreign material into the male external genitalia for augmentation: a single-centre experience and systematic review. Int J Impot Res. 2023 Mar 1. PMID: 36859681
8. Warren H, Wagner T, Gorin MA, ... Kasivisvanathan V, Moore CM, Campain N, Cartledge J, ... Gurusamy K, Emberton M, Tran MGB. (2023). Protocol for a MULTI-centre feasibility study to assess the use of 99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study). BMJ Open. 2023 Jan 24;13(1):e067496. PMID: 36693694
9. Campos-Juanatey F, Bugeja S, Dragova M, Frost AV, Ivaz SL, Andrich DE, Mundy AR. (2020). Single-stage tubular urethral reconstruction using oral grafts is an alternative to classical staged approach for selected penile urethral strictures. Asian J Androl. 2020 Mar-Apr;22(2):134-139. PMID: 31441450
10. Singh S, Rogers H, Kanber B, ... Shaw G, Heavey S, Stopka-Farooqui U, Haider A, Freeman A, Giganti F, Atkinson D, Moore CM, Whitaker HC, Alexander DC, Panagiotaki E, Punwani S. (2022). Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study. Radiology. 2022 Dec;305(3):623-630. Epub 2022 Aug 2.PMID: 35916679
11. Khetrapal, P., Stafford, R., Ó Scanaill, P., Kocadag, H., Kelly, J.D., et al. (2022). Measuring Patient Compliance With Remote Monitoring Following Discharge From Hospital After Major Surgery (DREAMPath): Protocol for a Prospective Observational Study. JMIR Research Protocols, 11 (4), e30638.
12. Kasivisvanathan, V., Chan, V.W.S., Clement, K. D., Emberton, M., Moore, C.M., et al. (2022). A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prostate cancer. PLoS ONE, 17, e0263345.
13. Ng, A., Khetrapal, P., Brew‐Graves, C., Muirhead, N., Kasivisvanathan, V., et al. (2022). Choosing appropriate patient‐reported outcome measures for prostate disease. BJUI Compass.
14. Orczyk, C., Barratt, D., Brew-Graves, C., Peng Hu, Y., Emberton, M., et al. (2021). Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer. J Urol, 101097JU0000000000001567.
15. Tan, W.S. & Kelly, J.D. (2021). Is delay to radical cystectomy following BCG failure oncologically safe? Nature Reviews Urology.
16. Stavrinides, V., Giganti, F., Orczyk, C., Emberton, M., Moore, C.M., et al. (2020). Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study. European Urology.
17. Giganti, F., Stavrinides, V., Stabile, A., Orczyk, C., Emberton, M., Moore, C.M., et al. (2020). Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISE. Br J Radiol, 20200819.
18. Stabile, A., Orczyk, C., Giganti, F., Emberton, M., Moore, C.M., et al. (2020). The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series. Eur Urol.
19. Giganti, F., Kirkham, A., Allen, C., Orczyk, C., Emberton, M. & Moore, C.M. (2020). Update on multiparametric prostate MRI during active surveillance: current and future trends and role of the PRECISE recommendations. The American journal of roentgenology, radium therapy, and nuclear medicine.
20. Dinneen E, Shaw GL, Kealy R, Alexandris P, Finnegan K, Chu K, Haidar N, Santos-Vidal S, Kudahetti S, Moore CM, Grey ADR, Berney DM, Sahdev A, Cathcart PJ, Oliver RTD, Rajan P, Cuzick J; PROVENT study group; (et al.) (2022). Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing. BJUI Compass. 2022 Jun 11;3(6):458-465. eCollection 2022 Nov.PMID: 362672